With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/10/cardiovascular-benefits-of-sglt2-inhibitors-glp-1-ras/" align="left"]
Preparing patients to be ready and confident to manage severe hypoglycemia will keep them safe and healthy. Fortunately, helping them use glucagon became a whole lot easier recently with the availability of new premixed formulations.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/08/a-renaissance-in-glucagon-ready-to-use-ready-to-have/" align="left"]
Priced at a third of the cost of other CGMs, this latest technology from Abbott is the first and only iCGM that sustains performance for up to 14 days and provides trends, insights and customizable high and low alerts.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/07/the-freestyle-libre-2-is-now-approved-what-are-the-differences-from-the-freestyle-libre-1/" align="left"]
Having the right information and treatment options can make all the difference for people with diabetes (and their friends and family) in order to lessen hypoglycemia worries and provide a better quality of life.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/01/how-to-boost-your-hypoglycemia-confidence-in-2020/" align="left"]
Everyone with diabetes on insulin therapy (or a medication that can cause low blood sugar) should know the signs, symptoms and treatments for hypoglycemia. New glucagon options to treat severe cases are already on the market, and more are on the way.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/09/lifesaving-tools-to-prevent-and-treat-hypoglycemia/" align="left"]
